T2‐Weighted MRI Correlates with Long‐Term Histopathology, Neurology Scores, and Skilled Motor Behavior in a Rat Stroke Model
暂无分享,去创建一个
D. Corbett | J. Peeling | M. R. Bigio | T. Hudzik | G. C. Palmer | M. Bigio
[1] D. Corbett,et al. Long-Term Functional End Points Following Middle Cerebral Artery Occlusion in the Rat , 2000, Pharmacology Biochemistry and Behavior.
[2] G. Sutherland,et al. AR-R15896AR reduces cerebral infarction volumes after focal ischemia in cats. , 2000, Neurosurgery.
[3] P M Matthews,et al. Relating MRI changes to motor deficit after ischemic stroke by segmentation of functional motor pathways. , 2000, Stroke.
[4] J. L. Raszkiewicz,et al. NPS 1506, A Novel NMDA Receptor Antagonist and Neuroprotectant: Review of Preclinical and Clinical Studies , 1999, Annals of the New York Academy of Sciences.
[5] S. Sydserff,et al. Efficacy of AR-R15896AR in the rat monofilament model of transient middle cerebral artery occlusion. , 1999, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[6] R. Ridley,et al. Functional Benefit from Clomethiazole Treatment after Focal Cerebral Ischemia in a Nonhuman Primate Species , 1999, Experimental Neurology.
[7] A. Buchan,et al. Continuing postischemic neuronal death in CA1: influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats. , 1999, Stroke.
[8] D. Corbett,et al. -(S)-Alpha-phenyl-2-pyridine-ethanamine Dihydrochloride-, a low affinity uncompetitive N-methyl-D-aspartic acid antagonist, is effective in rodent models of global and focal ischemia. , 1997, The Journal of pharmacology and experimental therapeutics.
[9] S. Warach,et al. Pitfalls and potential of clinical diffusion-weighted MR imaging in acute stroke. , 1997, Stroke.
[10] Michael Chopp,et al. The temporal evolution of MRI tissue signatures after transient middle cerebral artery occlusion in rat , 1997, Journal of the Neurological Sciences.
[11] J. Grotta,et al. Combined neuroprotection and reperfusion therapy for stroke. Effect of lubeluzole and diaspirin cross-linked hemoglobin in experimental focal ischemia. , 1996, Stroke.
[12] Reduction of excitotoxicity-induced brain damage by the competitive NMDA antagonist CGP 40116: a longitudinal study using diffusion-weighted imaging , 1996, Neuroscience Letters.
[13] D. Corbett,et al. Delayed postischemic hypothermia: a six month survival study using behavioral and histological assessments of neuroprotection. , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[14] D. Saunders,et al. Measurement of infarct size using MRI predicts prognosis in middle cerebral artery infarction. , 1995, Stroke.
[15] R. Busto,et al. HU-211, a novel noncompetitive N-methyl-D-aspartate antagonist, improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat. , 1995, Stroke.
[16] G. Steinberg,et al. Correlation of CGS 19755 Neuroprotection against in vitro Excitotoxicity and Focal Cerebral Ischemia , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[17] A. Tamura,et al. The Neuroprotective Effect of the Novel Noncompetitive NMDA Antagonist, FR115427 in Focal Cerebral Ischemia in Rats , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[18] R. Ordidge,et al. Magnetic Resonance Imaging Assessment of Evolving Focal Cerebral Ischemia Comparison With Histopathology in Rats , 1994, Stroke.
[19] B. Johansson,et al. Paw‐Reaching, Sensorimotor, and Rotational Behavior After Brain Infarction in Rats , 1993, Stroke.
[20] C. Sotak,et al. Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion‐weighted MRI , 1993, Neurology.
[21] B. Siesjö. Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment. , 1992, Journal of neurosurgery.
[22] B. Volpe,et al. Pharmacological Effects of Remacemide and MK-801 on Memory and Hippocampal CA1 Damage in the Rat Four-Vessel Occlusion (4-VO) Model of Global Ischemia , 1992 .
[23] P. Weinstein,et al. Reversible middle cerebral artery occlusion without craniectomy in rats. , 1989, Stroke.